AcBut	4-(4-acetylphenoxy) butanoic acid
ADC	Antibody drug conjugates
ALCL	anaplastic large cell lymphoma
ALL	Acute lymphoblastic leukaemia
AML	acute myeloid leukaemia
ANS	1-anilino-8-naphthale-neosulfonate
BCMA	B cell maturation antigen
cBu	cyclobutane-1,1-dicarboxamide
CDR	Complementarity determining region
CL2A	cleavable PEG8- and triazole-containing PABC–peptide–MC linker
CTLA4	cytotoxic T-lymphocyte associated antigen 4
Cys	Cysteine
DAR	Drug-antibody-ratio
DM1	derivative of maytansine/mertansine
DNA	Deoxyribonucleic Acid
DOX	doxorubicin
DXd	deruxtecan
ELISA	enzyme linked immunosorbent assay
EMA	European medicines agency
ER	estrogen receptor
EU	European Union
FDA	Food and drug administration
HER2	human epidermal growth factor receptor 2
HL	Hodgkin lymphoma
HPLC	High performance liquid chromatography
ICI	Immune checkpoint inhibition
IgG	Immunoglobulin G
IV	intravenous
Lys	lysine
mAb	Monoclonal antibody
MC	maleimidocaproyl
MCC	maleimidomethyl cyclohexane-1-carboxylate
MC-Val-Cit	Maleimidocaproyl Valine-Citrulline
MDR	Multi drug resistance
MMAE	Monomethyl auristatin E
MMAF	Monomethyl auristatin F
P-gp	P-glycoprotein
PAB	para-aminobenzyl
PBD	Pyrrolobenzodiazepines
PD-L1	Programmed cell Death-Ligand 1
PEG	Polyethylene glycol
PHB	p-hydroxybenzyl alcohol
PR	progesterone receptor
SC	subcutaneous
SEC-HPLC	size exclusion chromatography-high performance liquid chromatography
SMCC	Succinimidyl-4-[N-maleimidomethyl] cyclohexane-1-carboxylate)
SN-38	active metabolite of the topoisomerase I inhibitor irinotecan
SNP	single nucleotide polymorphisms
SPDB	N-succinimidyl-4-(2-pyridyldithio) butanoate
SPP	N-succinimidyl-4-(2-pyridyldithio) pentanoate
T-DM1	Trastuzumab emtansine
TGA	Therapeutic goods administration
ThT	thioflavin
TROP-2	tumor associated calcium signal transducer 2
Val-CitPABC	Valine-Citrulline para-aminobenzyloxycarbonyl
Val-Cit	Valine-Citrulline
VcMMAE	Valine-Citrulline monomethyl auristatin E